| Global changes in food supply and the obesity epidemic EH Zobel, TW Hansen, P Rossing, BJ von Scholten Current obesity reports 5, 449-455, 2016 | 242 | 2016 |
| Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational … N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ... The lancet Diabetes & endocrinology 8 (4), 301-312, 2020 | 196 | 2020 |
| Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study DM Maahs, L Caramori, DZI Cherney, AT Galecki, C Gao, D Jalal, ... Current diabetes reports 13, 550-559, 2013 | 162 | 2013 |
| Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer J Oellgaard, S Abitz Winther, T Schmidt Hansen, P Rossing, ... Current pharmaceutical design 23 (25), 3699-3712, 2017 | 122 | 2017 |
| Effects of liraglutide versus placebo on cardiovascular events in patients with type 2 diabetes mellitus and chronic kidney disease: results from the LEADER trial JFE Mann, V Fonseca, O Mosenzon, I Raz, B Goldman, T Idorn, ... Circulation 138 (25), 2908-2918, 2018 | 119 | 2018 |
| Current and future therapies for type 1 diabetes BJ von Scholten, FF Kreiner, SCL Gough, M von Herrath Diabetologia 64, 1037-1048, 2021 | 104 | 2021 |
| The effect of liraglutide on renal function: a randomized clinical trial BJ Von Scholten, F Persson, S Rosenlund, P Hovind, J Faber, ... Diabetes, Obesity and Metabolism 19 (2), 239-247, 2017 | 104 | 2017 |
| Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled … M von Herrath, SC Bain, B Bode, JO Clausen, K Coppieters, L Gaysina, ... The Lancet Diabetes & Endocrinology 9 (4), 212-224, 2021 | 93 | 2021 |
| Time course and mechanisms of the anti‐hypertensive and renal effects of liraglutide treatment BJ Von Scholten, M Lajer, JP Goetze, F Persson, P Rossing Diabetic Medicine 32 (3), 343-352, 2015 | 84 | 2015 |
| Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type … BJ von Scholten, H Reinhard, TW Hansen, CG Schalkwijk, C Stehouwer, ... Journal of Diabetes and its Complications 30 (2), 248-255, 2016 | 80 | 2016 |
| Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes RH Christensen, BJ von Scholten, CS Hansen, MT Jensen, T Vilsbøll, ... Cardiovascular diabetology 18, 1-10, 2019 | 77 | 2019 |
| Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes BJ Von Scholten, TW Hansen, JP Goetze, F Persson, P Rossing Journal of Diabetes and its Complications 29 (5), 670-674, 2015 | 77 | 2015 |
| Cardiac 82Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes BJ von Scholten, P Hasbak, TE Christensen, AA Ghotbi, A Kjaer, ... Diabetologia 59, 371-378, 2016 | 75 | 2016 |
| Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics PG Jørgensen, MT Jensen, R Mogelvang, BJ von Scholten, J Bech, ... Diabetes and Vascular Disease Research 13 (5), 321-330, 2016 | 68 | 2016 |
| Higher collagen VI formation is associated with all-cause mortality in patients with type 2 diabetes and microalbuminuria DGK Rasmussen, TW Hansen, BJ Von Scholten, SH Nielsen, H Reinhard, ... Diabetes Care 41 (7), 1493-1500, 2018 | 63 | 2018 |
| Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes … EH Zobel, BJ von Scholten, H Reinhard, F Persson, T Teerlink, ... Cardiovascular diabetology 16, 1-9, 2017 | 61 | 2017 |
| Effect of large weight reductions on measured and estimated kidney function BJ von Scholten, F Persson, MS Svane, TW Hansen, S Madsbad, ... BMC nephrology 18, 1-7, 2017 | 53 | 2017 |
| Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: a systematic review and meta‐analysis N Launbo, EH Zobel, BJ von Scholten, K Færch, PG Jørgensen, ... Obesity Reviews 22 (1), e13136, 2021 | 52 | 2021 |
| Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes? RH Christensen, BJ von Scholten, LL Lehrskov, P Rossing, PG Jørgensen Therapeutic Advances in Endocrinology and Metabolism 11, 2042018820928824, 2020 | 51 | 2020 |
| Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes RH Christensen, CS Hansen, BJ von Scholten, MT Jensen, BK Pedersen, ... Diabetes, Obesity and Metabolism 21 (8), 2006-2011, 2019 | 51 | 2019 |
